[Pathological study on the relationship between nucleic acid oxidative stress and heart failure with preserved

W R Zhu1, K Chai1, F Fang2

  • 1Department of Cardiology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China.

PubMed

Insights

Heart failure with preserved ejection fraction (HFpEF) in elderly patients shows increased RNA oxidation in heart muscle. Higher levels of RNA oxidation correlate with greater myocardial amyloid deposition.

Area of Science:

  • Cardiovascular pathology
  • Molecular biology
  • Geriatrics

Context:

  • Heart failure with preserved ejection fraction (HFpEF) is a growing concern in the elderly population.
  • The underlying mechanisms of HFpEF, particularly in advanced age, remain incompletely understood.
  • Oxidative stress and amyloid deposition are implicated in cardiac dysfunction.

Purpose:

  • To investigate the level of nucleic acid oxidation in the myocardium of elderly patients with HFpEF.
  • To examine the correlation between myocardial amyloid deposition and nucleic acid oxidation.
  • To compare RNA and DNA oxidation markers between HFpEF patients and a control group.

Summary:

  • This retrospective case-control study analyzed myocardial tissue from 26 HFpEF patients (≥85 years) and 13 controls.
  • Immunohistochemistry revealed significantly higher 8-oxidized guanine riboside (8-oxo-G, RNA oxidation) in HFpEF patients compared to controls (P=0.001).
  • DNA oxidation (8-oxidized guanine deoxyriboside, 8-oxo-dG) levels were similar between groups, but higher RNA oxidation correlated with increased myocardial amyloid deposition (P=0.001).

Impact:

  • Findings suggest elevated RNA oxidation is a characteristic of HFpEF in the elderly.
  • Increased myocardial amyloid deposition is associated with higher levels of RNA oxidation in this population.
  • This research may inform future therapeutic strategies targeting oxidative stress and amyloidosis in HFpEF.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
14
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
9
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
14
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
99